Legal & General Global Health & Pharmaceuticals Index Trust I Class Distribution
Category Sector Equity Healthcare
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
100.10p
0.32p (+0.32%)
Fund Code
LGGPI
B0CNH27
GB00B0CNH270
Prices updated as at 31 Oct 2024
Prices in GBX
Investment objective
The objective of the Fund is to track the performance of the FTSE World Index - Health Care (the “Benchmark Index”) on a net total return basis before fees and expenses are applied. Therefore, the Fund’s performance may differ from the Benchmark Index due to the deduction of fees and expenses and the impact of any tracking error factors. The Benchmark Index is comprised of shares in companies engaged in health, pharmaceuticals and biotechnology. The Fund is a Replicating Fund as it seeks to replicate as closely as possible the constituents of the Benchmark Index by holding all, or substantially all, of the assets comprising the Benchmark Index in similar proportions to their weightings in the Benchmark Index. The Fund will have at least 90% exposure to assets that are included in the Benchmark Index.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Dividend information
Dividend information | |
---|---|
- | |
1.20 | |
- | |
Annually | |
07 Mar 2024 |
Dividend history
Ex-div date | Per share amount | Reinvestment price |
---|---|---|
08 Jan 2024 | 0.01168 | 0.9433 |
09 Jan 2023 | 0.011227 | 0.9438 |
10 Jan 2022 | 0.00966 | 0.8701 |
08 Jan 2021 | 0.009214 | 0.806 |
08 Jan 2020 | 0.009974 | 0.7292 |
08 Jan 2019 | 0.009154 | 0.6333 |
08 Jan 2018 | 0.008523 | 0.5941 |
09 Jan 2017 | 0.007973 | 0.5584 |
Please note that past performance is not a reliable indicator of future returns.